For the Record
CHA advocates on behalf of the nation's children's hospitals and the patients and families we serve. This section includes CHA communications with federal policymakers such as statements for the record, RFI responses, regulatory comment letters, and more.
CHA Submits Response to Sen. Cassidy RFI on Diagnostic Test
Children’s Hospital Association submitted a response to Senate HELP Committee Ranking Member Sen. Cassidy's request for information on diagnostic testing tools.
CHA Responds to 340B Draft Bill and Request for Information
The 340B program supports children’s hospitals in their mission to serve low-income and underinsured children regardless of their insurance status.
CHA Submits Energy and Commerce Committee Statement for the Record on Laboratory Developed Tests
Children's Hospital Assocation submitted a statement for a legislative hearing to highlight the unique role LDTs play in pediatric health care.
CHA Submits Statement for the Record for Patients and Caregivers Hearing
Children's Hospital Association submitted a statement for a legislative hearing to highlight children’s needs when strengthening the pediatric drug supply chain.
CHA Response to Drug Shortages White Paper
CHA submitted comments on a drug shortages white paper to highlight pediatric health care needs.
CHA Response to Cell and Gene Therapy RFI
Cell and gene therapies have the potential to address unmet pediatric medical needs, reduce the need for costly chronic care, and help address health disparities.
CHA Comments on FDA Laboratory Developed Tests Proposed Rule
CHA’s comments urged the FDA to continue enforcement discretion for pediatric-related tests that enable children to continue to get needed care.
CHA Response to Medicare IPPS Proposed Rule for Fiscal Year 2024
CHA submitted comments for the Medicare IPPS proposed rule’s request for information on safety net hospitals.
CHA Submits Comments for Energy and Commerce Discussion Draft on Drug Shortages
CHA submitted a comment letter to the Energy and Commerce Committee to highlight pediatric needs when addressing drug shortages.
